Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,732 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,051 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00862082 | Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 1 / Phase 2 | 14 | Proacta, IncorporatedINDUSTRY | 4 | Aug 23, 2013 | clinicaltrials |
| NCT01010334 | Comparison of Standard of Care or Treatment on Protocol | terminated | N/A | 13 | New Mexico Cancer Research AllianceOTHER | 1 | Aug 14, 2013 | clinicaltrials |
| NCT00033306 | BMS-247550 in Treating Patients With Metastatic Colorectal Cancer | terminated | Phase 2 | 2 | University of Alabama at BirminghamOTHER | 1 | Aug 5, 2013 | clinicaltrials |
| NCT01476631 | Step Down Colon Cancer Risk | terminated | N/A | 17 | Washington University School of MedicineOTHER | 1 | Aug 5, 2013 | clinicaltrials |
| NCT00708877 | Liver Transplantation for Cholangiocarcinoma | terminated | N/A | 5 | University of UtahOTHER | 1 | Jul 30, 2013 | clinicaltrials |
| NCT00896467 | Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy | terminated | — | 200 | Centre Oscar LambretOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00932724 | CY-503 for the Treatment of Chemotherapy-refractory Metastatic Colorectal Cancer(CY503C2) | terminated | Phase 2 | 77 | Cytavis Biopharma GmbHINDUSTRY | 2 | Jul 10, 2013 | clinicaltrials |
| NCT00098527 | FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer | terminated | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT01282333 | Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer | terminated | Phase 1 | 44 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00587132 | Secretin (ChiRhoStim) Pancreas Perfusion for Pancreatic Adenocarcinoma | terminated | Phase 1 / Phase 2 | 4 | Mayo ClinicOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00398333 | Study to Assess the Effectiveness of a Omega-3 Enriched Supplement on Chemotherapy Tolerance in Colon Cancer Patients | terminated | Phase 4 | 13 | Hospital Clinic of BarcelonaOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00049608 | Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 51 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00908024 | Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors | terminated | Phase 1 / Phase 2 | 54 | Bristol-Myers SquibbINDUSTRY | 2 | Jun 18, 2013 | clinicaltrials |
| NCT01257035 | Predictive Value of 18F-FAZA in Rectum Cancer(FAZA) | terminated | — | 21 | Vejle HospitalOTHER | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00732082 | Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer | terminated | Phase 1 | 18 | Washington University School of MedicineOTHER | 1 | Jun 12, 2013 | clinicaltrials |
| NCT00084461 | Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00103272 | 17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic Cancer | terminated | Phase 1 | 74 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00006001 | SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer | terminated | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT01032291 | A Study to Assess the Efficacy and Safety of Lenalidomide in Combination With Cetuximab in Pre-treated Patients With KRAS Mutant Colorectal Cancer | terminated | Phase 2 | 51 | Celgene CorporationINDUSTRY | 6 | May 21, 2013 | clinicaltrials |
| NCT00012246 | Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | terminated | Phase 2 | 7 | The University of Texas Medical Branch, GalvestonOTHER | 1 | May 16, 2013 | clinicaltrials |
| NCT00354185 | PXD101 and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma | terminated | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | May 16, 2013 | clinicaltrials |
| NCT00268463 | Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer | terminated | Phase 3 | 22 | NSABP Foundation IncNETWORK | 1 | May 15, 2013 | clinicaltrials |
| NCT01853241 | Prospective Randomized Trial of Anterograde Single Balloon Versus Spirus Enteroscopy | terminated | — | 30 | Johns Hopkins UniversityOTHER | 1 | May 14, 2013 | clinicaltrials |
| NCT01189227 | Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery | terminated | Phase 3 | 9 | NSABP Foundation IncNETWORK | 1 | May 10, 2013 | clinicaltrials |
| NCT00006015 | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer | terminated | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01528501 | Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)(HDAC) | terminated | Phase 2 | 28 | Technical University of MunichOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT01466504 | Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin | terminated | — | 4 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Apr 15, 2013 | clinicaltrials |
| NCT00004193 | ISIS 2503 in Treating Patients With Metastatic and/or Locally Recurrent Colorectal Cancer | terminated | Phase 2 | 25 | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00828594 | Global Study Looking at the Combination of RAD001 and Sorafenib to Treat Patients With Advanced Hepatocellular Carcinoma | terminated | Phase 1 | 130 | Novartis PharmaceuticalsINDUSTRY | 5 | Apr 11, 2013 | clinicaltrials |
| NCT01271322 | Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG)(HICON) | terminated | Phase 2 | — | National Center for Tumor Diseases, HeidelbergOTHER | 1 | Apr 11, 2013 | clinicaltrials |
| NCT01329809 | Neoadjuvant Study of Recombinant Vaccinia Virus to Treat Metastatic Colorectal Carcinoma in Patients Undergoing Complete Resection of Liver Tumors | terminated | Phase 2 | 2 | Jennerex BiotherapeuticsINDUSTRY | 1 | Apr 10, 2013 | clinicaltrials |
| NCT01318447 | CyberKnife® for Hepatic Metastases From Colorectal Cancer | terminated | Phase 2 | 15 | Accuray IncorporatedINDUSTRY | 3 | Apr 8, 2013 | clinicaltrials |
| NCT00016029 | Comparison of Barium Enema, Computed Tomographic Colonography, and Colonoscopy in Detecting Colon Cancer | terminated | N/A | 775 | Duke UniversityOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00332280 | Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo | terminated | Phase 2 / Phase 3 | 67 | Auron Healthcare GmbHINDUSTRY | 2 | Mar 20, 2013 | clinicaltrials |
| NCT00405561 | Study to Evaluate Progression Free Survival in Cancer Patients With Advanced Colorectal Carcinoma With AMT2003 | terminated | Phase 2 / Phase 3 | 67 | Auron Healthcare GmbHINDUSTRY | 1 | Mar 20, 2013 | clinicaltrials |
| NCT00405873 | Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003 | terminated | Phase 2 | 73 | Auron Healthcare GmbHINDUSTRY | 1 | Mar 20, 2013 | clinicaltrials |
| NCT00662688 | Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer(PAM07) | terminated | Phase 3 | 42 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00937482 | Cediranib Maleate and Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer | terminated | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00608595 | Celecoxib in Treating Patients With Early-Stage Rectal Cancer | terminated | N/A | 10 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Mar 5, 2013 | clinicaltrials |
| NCT00889343 | Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer(FOSCO) | terminated | Phase 2 | 101 | AIO-Studien-gGmbHOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00950820 | Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer(VOXEL) | terminated | Phase 2 | 9 | AIO-Studien-gGmbHOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT00531115 | Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer. | terminated | Phase 2 | 28 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00003851 | Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer | terminated | N/A | 90 | Columbia UniversityOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00564720 | Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic Cancer | terminated | Phase 2 | 140 | Hellenic Oncology Research GroupOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT01455311 | Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic Tumors | terminated | — | 21 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00681876 | Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer | terminated | Phase 2 | 16 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00755534 | Irinotecan/Cetuximab Followed by XELOX/Cetuximab vs the Reverse Sequence in Metastatic CRC | terminated | Phase 2 | 68 | Hellenic Oncology Research GroupOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00003147 | Gene Therapy in Treating Patients With Cancer of The Liver | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00002796 | Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer | terminated | Phase 1 / Phase 2 | 46 | National Cancer Institute (NCI)NIH | 1 | Feb 1, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Aug 23, 2013source: clinicaltrials